Establishment of a LVAD Destination Program in a Swiss Non Cardiac Transplant University Hospital

Completed

• Conditions: Heart Implant Complication

• Registration Number: NCT04263012
• Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary

The goal of this study is to demonstrate the challenges and the effort to set up an artificial heart program as well as to report about the follow-up treatment and the mortality rate

Detailed Description

Not available

Study Timeline

• Study Start: 2019-12-01
• Primary Completion: 2019-12-31
• Study Completion: 2019-12-31
• Status Verified: 2020-02
• Study First Submitted: 2020-02-06
• Study First Submitted QC: 2020-02-06
• Study First Posted: 2020-02-10
• Last Update Submitted: 2020-02-18
• Last Update Posted: 2020-02-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Patients who received an LVAD implant

Exclusion Criteria

• not enough data collected
• stated will of the Patient, that his data can not be used

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
30 days mortality	30 days after surgery	mortality rate 30 days after receiving the LVAD implant
rehospitalization rate	between day of surgery and 31.12.2019	rehospitalization rate of patients after receiving the LVAD implant

Secondary Outcome Measures

Name	Time	Method
survival rate	between day of surgery and 31.12.2019	survival rate of patients after receiving the LVAD implant (Kaplan-Meier curve)

Trial Locations

Locations (1)

Herzchirurgie University Hospital Basel; 🇨🇭 Basel, Switzerland